Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses

References

• Coura JR, Vinas PA. Chagas disease: a new worldwide challenge. Nature. 2010; 465: S6–7.
   PubMed Web of Science ®Google Scholar
• Tyler KM, Engman DM. The life cycle of Trypanosoma cruzi revisited. Int J Parasitol. 2001; 31: 472–81.
   PubMed Web of Science ®Google Scholar
• Burleigh BA, Woolsey AM. Cell signalling and Trypanosoma cruzi invasion. Cell Microbiol. 2002; 4: 701–11.
   PubMed Web of Science ®Google Scholar
• Burleigh BA. Host cell signaling and Trypanosoma cruzi invasion: do all roads lead to lysosomes?. Sci STKE. 2005; 2005: pe36.
   Google Scholar
• Caradonna KL, Burleigh BA. Mechanisms of host cell invasion by Trypanosoma cruzi. Adv Parasitol. 2011; 76: 33–61.
   PubMed Web of Science ®Google Scholar
• Mott A, Lenormand G, Costales J, Fredberg JJ, Burleigh BA. Modulation of host cell mechanics by Trypanosoma cruzi. J Cell Physiol. 2009; 218: 315–22.
   Web of Science ®Google Scholar
• Ouaissi A, Ouaissi M. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases. Arch Immunol Ther Exp (Warsz). 2005; 53: 102–14.
   Web of Science ®Google Scholar
• Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol. 2001; 167: 416–23.
   PubMed Web of Science ®Google Scholar
• Dutra WO, Menezes CA, Magalhaes LM, Gollob KJ. Immunoregulatory networks in human Chagas disease. Parasite Immunol. 2014; 36: 377–87.
   Web of Science ®Google Scholar
• Basso B, Marini V. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: reality or fiction?. Immunobiology. 2014; 219: 275–84.
   Web of Science ®Google Scholar
• Basso B. Modulation of immune response in experimental Chagas disease. World J Exp Med. 2013; 3: 1–10.
   PubMedGoogle Scholar
• Dc-Rubin SS, Schenkman S. Trypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas’ disease. Cell Microbiol. 2012; 14: 1522–30.
   PubMed Web of Science ®Google Scholar
• Mattos EC, Tonelli RR, Colli W, Alves MJ. The Gp85 surface glycoproteins from Trypanosoma cruzi. Subcell Biochem. 2014; 74: 151–80.
   Google Scholar
• Alves MJ, Colli W. Trypanosoma cruzi: adhesion to the host cell and intracellular survival. IUBMB Life. 2007; 59: 274–9.
   Web of Science ®Google Scholar
• Magdesian MH, Tonelli RR, Fessel MR, Silveira MS, Schumacher RI, Linden R et al. A conserved domain of the gp85/trans-sialidase family activates host cell extracellular signal-regulated kinase and facilitates Trypanosoma cruzi infection. Exp Cell Res. 2007; 313: 210–18.
   PubMed Web of Science ®Google Scholar
• Soares RP, Torrecilhas AC, Assis RR, Rocha MN, Moura e Castro FA, Freitas GF et al. Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of alpha-galactosyl residues. Am J Trop Med Hyg. 2012; 87: 87–96.
   Web of Science ®Google Scholar
• Acosta-Serrano A, Almeida IC, Freitas-Junior LH, Yoshida N, Schenkman S. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Mol Biochem Parasitol. 2001; 114: 143–50.
   Web of Science ®Google Scholar
• Goncalves MF, Umezawa ES, Katzin AM, de Souza W, Alves MJ, Zingales B et al. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp Parasitol. 1991; 72: 43–53.
   PubMed Web of Science ®Google Scholar
• Trocoli Torrecilhas AC, Tonelli RR, Pavanelli WR, da Silva JS, Schumacher RI, de Souza W et al. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 2009; 11: 29–39.
   PubMed Web of Science ®Google Scholar
• Torrecilhas AC, Schumacher RI, Alves MJ, Colli W. Vesicles as carriers of virulence factors in parasitic protozoan diseases. Microbes Infect. 2012; 14: 1465–74.
   Web of Science ®Google Scholar
• Hong SW, Choi EB, Min TK, Kim JH, Kim MH, Jeon SG et al. An important role of alpha-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus. PLoS One. 2014; 9: e100499.
   Web of Science ®Google Scholar
• Marcilla A, Martin-Jaular L, Trelis M, de Menezes-Neto A, Osuna A, Bernal D et al. Extracellular vesicles in parasitic diseases. J Extracell Vesicles. 2014; 3: 25040.
   PubMedGoogle Scholar
• Campos JH, Soares RP, Ribeiro K, Cronemberger Andrade A, Batista WL, Torrecilhas AC. Extracellular vesicles: role in inflammatory responses and potential uses in vaccination in cancer and infectious diseases. J Immunol Res. 2015; 2015: 832057.
   PubMed Web of Science ®Google Scholar
• Geiger A, Hirtz C, Becue T, Bellard E, Centeno D, Gargani D et al. Exocytosis and protein secretion in Trypanosoma. BMC Microbiol. 2010; 10: 20.
   PubMed Web of Science ®Google Scholar
• Silverman JM, Clos J, de'Oliveira CC, Shirvani O, Fang Y, Wang C et al. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J Cell Sci. 2010; 123: 842–52.
   PubMed Web of Science ®Google Scholar
• Silverman JM, Reiner NE. Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection. Front Cell Infect Microbiol. 2011; 1: 26.
   Web of Science ®Google Scholar
• Silverman JM, Clos J, Horakova E, Wang AY, Wiesgigl M, Kelly I et al. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J Immunol. 2010; 185: 5011–22.
   PubMed Web of Science ®Google Scholar
• Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O et al. A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz. 2009; 104: 1051–4.
   PubMed Web of Science ®Google Scholar
• Andrews NW, Colli W. Adhesion and interiorization of Trypanosoma cruzi in mammalian cells. J Protozool. 1982; 29: 264–9.
   PubMedGoogle Scholar
• Uphoff CC, Drexler HG. Detection of mycoplasma contaminations. Methods Mol Biol. 2005; 290: 13–23.
   Google Scholar
• Soares RP, Cardoso TL, Barron T, Araujo MS, Pimenta PF, Turco SJ. Leishmania braziliensis: a novel mechanism in the lipophosphoglycan regulation during metacyclogenesis. Int J Parasitol. 2005; 35: 245–53.
   Web of Science ®Google Scholar
• Paranaiba L, de Assis R, Nogueira P, Torrecilhas A, Campos J, Silveira A et al. Leishmania enriettii: biochemical characterisation of lipophosphoglycans (LPGs) and glycoinositolphospholipids (GIPLs) and infectivity to Cavia porcellus. Parasit Vectors. 2015; 8: 31.
   Web of Science ®Google Scholar
• Assis RR, Ibraim IC, Noronha FS, Turco SJ, Soares RP. Glycoinositolphospholipids from Leishmania braziliensis and L. infantum: modulation of innate immune system and variations in carbohydrate structure. PLoS Negl Trop Dis. 2012; 6: e1543.
   Web of Science ®Google Scholar
• Torrecilhas AC, Faquim-Mauro E, Da Silva AV, Abrahamsohn IA. Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi. Immunology. 1999; 96: 381–8.
   Web of Science ®Google Scholar
• Sathler-Avelar R, Vitelli-Avelar DM, Massara RL, Borges JD, Lana M, Teixeira-Carvalho A et al. Benznidazole treatment during early-indeterminate Chagas’ disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile. Scand J Immunol. 2006; 64: 554–63.
   Web of Science ®Google Scholar
• Dutra WO, Colley DG, Pinto-Dias JC, Gazzinelli G, Brener Z, Pereira ME et al. Self and nonself stimulatory molecules induce preferential expansion of CD5+ B cells or activated T cells of chagasic patients, respectively. Scand J Immunol. 2000; 51: 91–7.
   Web of Science ®Google Scholar
• Almeida IC, Camargo MM, Procopio DO, Silva LS, Mehlert A, Travassos LR et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 2000; 19: 1476–85.
   PubMed Web of Science ®Google Scholar
• Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol. 2005; 83: 674–86.
   PubMed Web of Science ®Google Scholar
• Almeida IC, Milani SR, Gorin PA, Travassos LR. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies. J Immunol. 1991; 146: 2394–400.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Pereira ME, Romanha A, Gazzinelli G, Brener Z. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Parasite Immunol. 1991; 13: 345–56.
   Web of Science ®Google Scholar
• Almeida IC, Ferguson MA, Schenkman S, Travassos LR. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas’ disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J. 304: 793–802.
   Google Scholar
• Talvani A, Ribeiro CS, Aliberti JC, Michailowsky V, Santos PV, Murta SM et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2000; 2: 851–66.
   Web of Science ®Google Scholar
• Di Girolamo F, Raggi C, Birago C, Pizzi E, Lalle M, Picci L et al. Plasmodium lipid rafts contain proteins implicated in vesicular trafficking and signalling as well as members of the PIR superfamily, potentially implicated in host immune system interactions. Proteomics. 2008; 8: 2500–13.
   Web of Science ®Google Scholar
• Hassani K, Olivier M. Immunomodulatory impact of Leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis. PLoS Negl Trop Dis. 2013; 7: e2185.
   PubMed Web of Science ®Google Scholar
• Marcilla A, Trelis M, Cortes A, Sotillo J, Cantalapiedra F, Minguez MT et al. Extracellular vesicles from parasitic helminths contain specific excretory/secretory proteins and are internalized in intestinal host cells. PLoS One. 2012; 7: e45974.
   PubMed Web of Science ®Google Scholar
• Ferguson MA. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci. 1999; 112: 2799–809.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Denkers EY. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol. 2006; 6: 895–906.
   PubMed Web of Science ®Google Scholar
• Oliveira AC, Peixoto JR, de Arruda LB, Campos MA, Gazzinelli RT, Golenbock DT et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol. 2004; 173: 5688–96.
   PubMed Web of Science ®Google Scholar
• Giordanengo L, Guinazu N, Stempin C, Fretes R, Cerban F, Gea S. Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur J Immunol. 2002; 32: 1003–11.
   Web of Science ®Google Scholar
• Pineda MA, Corvo L, Soto M, Fresno M, Bonay P. Interactions of human galectins with Trypanosoma cruzi: binding profile correlate with genetic clustering of lineages. Glycobiology. 2015; 25: 197–210.
   Web of Science ®Google Scholar
• Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013; 13: 679–92.
   PubMed Web of Science ®Google Scholar
• Ropert C, Almeida IC, Closel M, Travassos LR, Ferguson MA, Cohen P et al. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J Immunol. 2001; 166: 3423–31.
   Web of Science ®Google Scholar
• Ropert C, Gazzinelli RT. Regulatory role of toll-like receptor 2 during infection with Trypanosoma cruzi. J Endotoxin Res. 2004; 10: 425–30.
   PubMedGoogle Scholar
• Ibraim IC, de Assis RR, Pessoa NL, Campos MA, Melo MN, Turco SJ et al. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Parasit Vectors. 2013; 6: 54.
   PubMed Web of Science ®Google Scholar
• Rassi A Jr., Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010; 375: 1388–402.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Ropert C, Campos MA. Role of the toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol Rev. 2004; 201: 9–25.
   PubMed Web of Science ®Google Scholar
• Lima MT, Lenzi HL, Gattass CR. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi. Parasitol Res. 1995; 81: 6–12.
   Web of Science ®Google Scholar
• Souza PE, Rocha MO, Rocha-Vieira E, Menezes CA, Chaves AC, Gollob KJ et al. Monocytes from patients with indeterminate and cardiac forms of Chagas’ disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun. 2004; 72: 5283–91.
   PubMed Web of Science ®Google Scholar
• Vitelli-Avelar DM, Sathler-Avelar R, Teixeira-Carvalho A, Pinto Dias JC, Gontijo ED, Faria AM et al. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease. Scand J Immunol. 2008; 68: 516–25.
   PubMed Web of Science ®Google Scholar
• Sathler-Avelar R, Vitelli-Avelar DM, Teixeira-Carvalho A, Martins-Filho OA. Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?. Mem Inst Oswaldo Cruz. 2009; 104(Suppl 1): 246–51.
   Web of Science ®Google Scholar
• Sathler-Avelar R, Vitelli-Avelar DM, Eloi-Santos SM, Gontijo ED, Teixeira-Carvalho A, Martins-Filho OA. Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens. BMC Infect Dis. 2012; 12: 123.
   PubMed Web of Science ®Google Scholar
• Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ et al. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis. 2009; 199: 451–4.
   Web of Science ®Google Scholar
• Dutra WO, Martins-Filho OA, Cancado JR, Pinto-Dias JC, Brener Z, Freeman Junior GL et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas’ disease. Int Immunol. 1994; 6: 499–506.
   Web of Science ®Google Scholar
• Bryan MA, Guyach SE, Norris KA. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. PLoS Negl Trop Dis. 2010; 4: e733.
   Web of Science ®Google Scholar
• Bermejo DA, Amezcua-Vesely MC, Montes CL, Merino MC, Gehrau RC, Cejas H et al. BAFF mediates splenic B cell response and antibody production in experimental Chagas disease. PLoS Negl Trop Dis. 2010; 4: e679.
   PubMed Web of Science ®Google Scholar
• Fares RC, Correa-Oliveira R, de Araujo FF, Keesen TS, Chaves AT, Fiuza JA et al. Identification of phenotypic markers of B cells from patients with Chagas disease. Parasite Immunol. 2013; 35: 214–23.
   Web of Science ®Google Scholar
• Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J Immunol. 2004; 172: 3422–7.
   PubMed Web of Science ®Google Scholar
• Souza PE, Rocha MO, Menezes CA, Coelho JS, Chaves AC, Gollob KJ et al. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas’ disease. Infect Immun. 2007; 75: 1886–94.
   PubMed Web of Science ®Google Scholar
• Gravina HD, Antonelli L, Gazzinelli RT, Ropert C. Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi. PLoS One. 2013; 8: e63100.
   Web of Science ®Google Scholar